Network and receptor architectures shape brain morphometry in addiction
Georgiadis, F.; Milano, B. A.; Lariviere, S.; Hutchinson, K. E.; Calhoun, V.; Li, C.-S. R.; Momenan, R.; Sinha, R.; Veltman, D.; van Holst, R.; Goudriaan, A.; Luijten, M.; Groefsema, M.; Walter, H.; Lett, T.; Wiers, R.; Schmaal, L.; Flanagan, J.; Porjesz, B.; Ipser, J.; Boehmer, J.; Canessa, N.; Salas, R.; London, E.; Paulus, M.; Stein, D.; Brooks, S.; Reneman, L.; Schrantee, A.; Filbey, F.; Hester, R.; Yucel, M.; Lorenzetti, V.; Solowij, N.; Martin-Santos, R.; Batalla, A.; Cousijn, J.; Pomarol-Clotet, E.; Garza-Villarreal, E. A.; Leyton, M.; Stein, E.; Crunelle, C. L.; Kaag, A. M.; Verdejo-Ga
Show abstract
Substance use disorders (SUD) are chronic conditions with devastating effects on brain health, functioning, and survival. In this study, we compared brain morphometry of 2,782 individuals with SUD to 1,951 controls and assessed the topographic overlap of these differences with brain connectivity and receptor architecture. Across SUD, we identified a morphometric signature involving frontal, parietal, temporal and limbic systems that overlapped with cortical hub regions and harbored cortical and subcortical disease epicenters. Findings were highly consistent across six substances and numerous robustness and generalizability analyses. Transdiagnostic comparisons showed high spatial overlap of SUD epicenters with those of schizophrenia and bipolar disorder, suggesting shared network-constrained cortical differences. Finally, multivariate mapping revealed that SUD brain differences aligned with two neurotransmitter axes contrasting cannabinoid-opioid and dopaminergic systems. These findings indicate that addiction-related brain differences are shaped by connectome and neurotransmitter architecture, positioning brain network and neurochemical organization as key principles of SUD-related brain alterations.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.